Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Heart Disease: Major Risk Factor for Many Rheumatology Patients

Vanessa Caceres  |  Issue: October 2015  |  October 14, 2015

Heart Disease: Major Risk Factor for Many Rheumatology Patients

Image Credit: TEFI/shutterstock.com

Rheumatic diseases, such as rheuma­toid arthritis (RA), systemic lupus erythematosus (SLE) and vasculitis, can affect the body in many ways, but perhaps the most serious is the increased risk of heart disease for many patients.

As the risk of atherosclerosis in autoimmune disease patients gains increased attention, rheumatologists and cardiologists are collaborating more often to refer patients to each other and, at some institutions, see patients in a combined clinic.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The ultimate goal is to decrease inflammation to control rheumatic disease and lower the risk for heart disease, says cardiologist Donna Denier, MD, Franklin Square, N.Y. “When you see a reduction in inflammation, you see a reduction in cardiac mortality as well,” she says.

The Challenges

Although rheumatologists focus on the joints, it’s only natural to evaluate the patient as a whole person with preexisting conditions or risk factors that could be caused by rheumatic disease, says rheumatologist Orrin Troum, MD, Providence Saint John’s Health Center, Santa Monica, Calif.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Of course, patients with a disease such as RA who are also at increased risk for cardiovascular disease can’t be cured overnight. These patients bring a number of challenges, in addition to the usual challenges of treating inflammatory disease.

“One major challenge includes awareness of the increased risk and initiating the conversation with the patient about the need for risk assessment and management,” says Eric Matteson, MD, rheumatology chair at Mayo Clinic, Rochester, Minn.

Patients with RA or related diseases may not even know they are at greater risk for cardiovascular disease, but the risk is almost equal to the increased risk that diabetic patients have, Dr. Denier says. Additionally, cardiovascular signs may appear at an earlier age in these patients than in a normal patient population.

Another challenge is evaluating a patient’s medications that could further increase the risk for heart disease. For example, rheumatologists often prescribe steroids, which do not interact well with the aspirin or anti-platelet drugs a cardiologist might prescribe, Dr. Denier says.

Additionally, certain drugs used to treat RA, such as prednisone, can increase risks to the heart, says rheumatologist M. Elaine Husni, MD, MPH, director, Arthritis & Musculoskeletal Treatment Center, Cleveland Clinic, Cleveland.

Some RA drugs may cause worsening or death in established heart failure patients, says Sabahat Bokhari, MD, associate professor of medicine-cardiology, and director of nuclear cardiology, Columbia University Medical Center, New York Presbyterian Hospital, New York.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:cardiologistsClinicalHeart Diseasepatient careRARheumatoid arthritisrheumatologistrisk

Related Articles

    Psoriatic Arthritis & the Obese Patient

    November 6, 2022

    Estimates from the National Psoriasis Foundation indicate that more than 8 million people in the U.S. suffer from psoriasis and that approximately 30% of those individuals develop psoriatic arthritis (PsA).1 Given these statistics, roughly 2.4 million people in the country are likely affected by PsA. Moreover, patients with this systemic condition carry a higher-than-average burden…

    Journey from Early Career Grant Recipient to Preceptor

    August 1, 2011

    Elaine Husni, MD, MPH, knew from an early age that she wanted to be a doctor. Along the way, she relied on the support of mentors and the ACR Research and Education Foundation Awards and Grants program to help establish her career in rheumatology, eventually landing her in her current role as the department vice chair for the Arthritis and Musculoskeletal Center at the Cleveland Clinic.

    Minimizing Disease Activity in Psoriatic Arthritis

    October 15, 2021

    The use of objective, validated outcome measures to track progress in symptom control for patients with psoriatic arthritis was discussed in a session at the 2019 ACR/ARP Annual Meeting titled Optimizing Outcomes in Psoriatic Arthritis: A Domain-Based Strategy. In the years since this presentation, additional research has helped supply greater insights into this topic and…

    Heart to Heart: Cardiovascular Disease in Autoimmune Conditions

    December 2, 2021

    During the ACR Convergence 2021 Review Course, Joan Bathon, MD, discussed cardiovascular manifestations of autoimmune diseases, including rheumatoid arthritis.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences